CN105188720A - 用作药物或膳食活性成分的多孔硅材料 - Google Patents

用作药物或膳食活性成分的多孔硅材料 Download PDF

Info

Publication number
CN105188720A
CN105188720A CN201380069421.3A CN201380069421A CN105188720A CN 105188720 A CN105188720 A CN 105188720A CN 201380069421 A CN201380069421 A CN 201380069421A CN 105188720 A CN105188720 A CN 105188720A
Authority
CN
China
Prior art keywords
porous silicon
range
pores
silicon material
silicon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380069421.3A
Other languages
English (en)
Chinese (zh)
Inventor
罗伯特·斯卡兹
托尔·本特松
纳塔利娅·库普弗施密特
阿方索·E·加西亚-班尼特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanologica AB
Original Assignee
Nanologica AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanologica AB filed Critical Nanologica AB
Priority to CN202110214365.4A priority Critical patent/CN113069467A/zh
Publication of CN105188720A publication Critical patent/CN105188720A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/12—Surface area
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/14—Pore volume
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/16—Pore diameter
    • C01P2006/17—Pore diameter distribution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Silicon Compounds (AREA)
CN201380069421.3A 2012-11-06 2013-11-06 用作药物或膳食活性成分的多孔硅材料 Pending CN105188720A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110214365.4A CN113069467A (zh) 2012-11-06 2013-11-06 用作药物或膳食活性成分的多孔二氧化硅材料

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261723019P 2012-11-06 2012-11-06
US61/723,019 2012-11-06
PCT/EP2013/073200 WO2014072363A1 (en) 2012-11-06 2013-11-06 A porous silica material for use as a pharmaceutical or dietary active ingredient

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202110214365.4A Division CN113069467A (zh) 2012-11-06 2013-11-06 用作药物或膳食活性成分的多孔二氧化硅材料

Publications (1)

Publication Number Publication Date
CN105188720A true CN105188720A (zh) 2015-12-23

Family

ID=49639855

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202110214365.4A Pending CN113069467A (zh) 2012-11-06 2013-11-06 用作药物或膳食活性成分的多孔二氧化硅材料
CN201380069421.3A Pending CN105188720A (zh) 2012-11-06 2013-11-06 用作药物或膳食活性成分的多孔硅材料

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202110214365.4A Pending CN113069467A (zh) 2012-11-06 2013-11-06 用作药物或膳食活性成分的多孔二氧化硅材料

Country Status (20)

Country Link
US (2) US10695294B2 (enExample)
EP (2) EP2916852B1 (enExample)
JP (2) JP6421124B2 (enExample)
CN (2) CN113069467A (enExample)
AU (1) AU2013343565B2 (enExample)
BR (1) BR112015010118A2 (enExample)
CA (3) CA2890171C (enExample)
CY (1) CY1124471T1 (enExample)
DK (1) DK2916852T3 (enExample)
ES (1) ES2878017T3 (enExample)
HR (1) HRP20211036T1 (enExample)
HU (1) HUE055017T2 (enExample)
IL (1) IL238538B (enExample)
LT (1) LT2916852T (enExample)
PH (1) PH12015501010B1 (enExample)
PL (1) PL2916852T3 (enExample)
PT (1) PT2916852T (enExample)
SI (1) SI2916852T1 (enExample)
WO (1) WO2014072363A1 (enExample)
ZA (1) ZA201502979B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110314151A (zh) * 2019-08-02 2019-10-11 深圳国佳产业基金管理有限公司 医用介孔二氧化硅材料及其应用

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113069467A (zh) 2012-11-06 2021-07-06 西格丽德治疗公司 用作药物或膳食活性成分的多孔二氧化硅材料
EP2934495B1 (en) * 2012-12-21 2017-07-19 National Health Research Institutes Mesoporous silica nanoparticles for oil absorption
EP3651789A4 (en) * 2017-07-13 2021-05-26 Carnegie Mellon University METHOD OF INCREASING EPITHELIAL PERMEABILITY USING NANOPARTICLES
WO2019116258A1 (en) * 2017-12-13 2019-06-20 L.I.Co.Rice S.R.L. Complex of lactoferrin and silica, process for preparing and compositions for oral hygiene
GB201803363D0 (en) * 2018-03-01 2018-04-18 Sigrid Therapeutics Ab New materials and uses thereof
CN113454456B (zh) * 2019-04-15 2024-08-20 纳诺洛吉卡股份公司 用于治疗、预防和/或延缓神经退行性疾病以及神经元和神经胶质退化的空多孔颗粒
WO2021062538A1 (en) * 2019-09-30 2021-04-08 Zeroignition Technologies Inc. Thermally insulating and fire retardant material and method for making same
JP7578945B2 (ja) * 2020-10-27 2024-11-07 信越化学工業株式会社 イミダゾールシラン処理シリカからなる胆汁酸吸着剤
CN114195885B (zh) * 2022-01-12 2024-04-26 杭州隆基生物技术有限公司 一种单克隆抗体组合物提纯方法
KR20240151778A (ko) 2022-02-04 2024-10-18 시그리드 테라퓨틱스 에이비 다공성 실리카 입자를 포함하는 구강 관리 조성물
JP2025119063A (ja) 2022-04-28 2025-08-14 日本たばこ産業株式会社 無機多孔質材料を含む口腔用組成物
GB202212240D0 (en) 2022-08-23 2022-10-05 Sigrid Therapeutics Ab New formulations and medical uses thereof
GB202212239D0 (en) 2022-08-23 2022-10-05 Sigrid Therapeutics Ab New dietary supplements
CN116747321B (zh) * 2023-06-14 2025-09-05 厦门君德医药科技有限公司 一种接枝改性的介孔二氧化硅及其制备方法和应用
GB202312179D0 (en) 2023-08-09 2023-09-20 Sigrid Therapeutics Ab New compositions and uses
GB202312176D0 (en) 2023-08-09 2023-09-20 Sigrid Therapeutics Ab New uses and methods

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180566A (en) * 1978-05-15 1979-12-25 W. R. Grace & Co. Silica gel method of reducing blood lipid concentration
US20040001862A1 (en) * 2002-05-01 2004-01-01 Rulin Xiu Compositions and methods for body weight loss
CN101296625A (zh) * 2005-07-27 2008-10-29 Psi医疗有限公司 含硅的食品
WO2010050897A1 (en) * 2008-10-28 2010-05-06 Agency For Science, Technology And Research Mesoporous material excipients for poorly aqueous soluble ingredients
CN102084567A (zh) * 2009-06-03 2011-06-01 空中客车作业有限公司 电子单元的雷电防护装置
CN102083456A (zh) * 2008-03-25 2011-06-01 阿姆拉特斯治疗公司 神经退行性障碍

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185088A (en) 1977-02-17 1980-01-22 Merck & Co., Inc. Non-adhesive ionene quaternary polymer compositions useful as bile acid sequestrants
US4824672A (en) * 1986-06-06 1989-04-25 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
US5401466A (en) * 1993-06-01 1995-03-28 Miles Inc. Device for the direct measurement of low density lipoprotein cholesterol
EP0778027A3 (de) 1995-12-04 1998-04-01 Helmut Univ.-Prof. Dr. Wachter Verwendung von Kieselerde zur Herstellung von Arzneimitteln
EP0911078A1 (en) * 1997-10-20 1999-04-28 Hitachi Metals, Ltd. Photocatalyst-supporting body and photocatalytic apparatus
EP1093370B1 (en) * 1998-06-30 2006-02-22 Takeda Pharmaceutical Company Limited Pharmaceutical composition for the treatment of diabetes
CA2380941A1 (en) * 1999-08-16 2001-02-22 Henceforth Hibernia, Inc. Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them
AU2001289699B2 (en) 2000-07-28 2006-06-01 Cheplapharm Arzneimittel Gmbh New pharmaceutical composition
JP2004345895A (ja) 2003-05-21 2004-12-09 Ajinomoto Co Inc メソポーラスシリカ及びその製造方法
JP2005289853A (ja) 2004-03-31 2005-10-20 Ajinomoto Co Inc 経口リン酸吸着剤
KR100857411B1 (ko) 2006-07-21 2008-09-08 한올제약주식회사 리파아제 저해제의 경구 투여용 방출조절 약학 제제 및이의 제조 방법
AU2009214118B2 (en) 2008-02-11 2014-06-12 Nanologica Ab Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials
TW200936130A (en) * 2008-02-26 2009-09-01 Lundbeck & Co As H Uses of indane compounds
JP2010065023A (ja) 2008-08-14 2010-03-25 Lion Corp 脂溶性ビタミンおよび／または脂溶性色素含有粉体
EP2547733A1 (en) 2010-03-17 2013-01-23 Nanologica AB Enhanced folic acid fluorescent material, multifluorescent porous compositions of matter and potential applications thereof
DK2590661T3 (da) * 2010-07-06 2020-01-27 Nanologica Ab Forbedret fremgangsmåde til stamcelledifferentiering in vivo ved afgivelse af morfogener med mesoporøst siliciumdioxid og tilsvarende farmaceutisk aktive bestanddele
GB201212866D0 (en) 2012-07-20 2012-09-05 Formac Pharmaceuticals Nv Dry granulates of mesoporous silica powders
CN113069467A (zh) 2012-11-06 2021-07-06 西格丽德治疗公司 用作药物或膳食活性成分的多孔二氧化硅材料
HK1216240A1 (zh) 2012-11-14 2016-10-28 W. R. Grace & Co.-Conn. 含有生物活性材料与无序无机氧化物的组合物
EP2934495B1 (en) 2012-12-21 2017-07-19 National Health Research Institutes Mesoporous silica nanoparticles for oil absorption

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180566A (en) * 1978-05-15 1979-12-25 W. R. Grace & Co. Silica gel method of reducing blood lipid concentration
US20040001862A1 (en) * 2002-05-01 2004-01-01 Rulin Xiu Compositions and methods for body weight loss
CN101296625A (zh) * 2005-07-27 2008-10-29 Psi医疗有限公司 含硅的食品
CN102083456A (zh) * 2008-03-25 2011-06-01 阿姆拉特斯治疗公司 神经退行性障碍
WO2010050897A1 (en) * 2008-10-28 2010-05-06 Agency For Science, Technology And Research Mesoporous material excipients for poorly aqueous soluble ingredients
CN102084567A (zh) * 2009-06-03 2011-06-01 空中客车作业有限公司 电子单元的雷电防护装置

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MICHAL KRUK ETAL: ""Characterization of the Porous Structure of SBA-15"", 《BIOMED RESEARCH INTERNATIONAL》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110314151A (zh) * 2019-08-02 2019-10-11 深圳国佳产业基金管理有限公司 医用介孔二氧化硅材料及其应用

Also Published As

Publication number Publication date
ES2878017T3 (es) 2021-11-18
US10695294B2 (en) 2020-06-30
LT2916852T (lt) 2021-06-25
EP2916852B1 (en) 2021-04-14
WO2014072363A1 (en) 2014-05-15
US20200390703A1 (en) 2020-12-17
HUE055017T2 (hu) 2021-10-28
AU2013343565B2 (en) 2018-07-26
CN113069467A (zh) 2021-07-06
ZA201502979B (en) 2024-09-25
HRP20211036T1 (hr) 2021-10-01
PL2916852T3 (pl) 2021-11-02
EP3892285A3 (en) 2021-11-17
EP3892285A2 (en) 2021-10-13
JP2019023222A (ja) 2019-02-14
PH12015501010A1 (en) 2015-07-27
IL238538A0 (en) 2015-06-30
JP6421124B2 (ja) 2018-11-07
BR112015010118A2 (pt) 2017-07-11
CA3024640A1 (en) 2014-05-15
CA3024460A1 (fr) 2018-11-15
CA2890171C (en) 2019-01-22
CA2890171A1 (en) 2014-05-15
IL238538B (en) 2019-06-30
EP2916852A1 (en) 2015-09-16
JP2015536939A (ja) 2015-12-24
PH12015501010B1 (en) 2023-10-20
AU2013343565A1 (en) 2015-05-21
PT2916852T (pt) 2021-06-15
DK2916852T3 (en) 2021-05-10
SI2916852T1 (sl) 2021-08-31
CY1124471T1 (el) 2022-07-22
US12121612B2 (en) 2024-10-22
JP6752858B2 (ja) 2020-09-09
US20150258028A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
US12121612B2 (en) Porous silica material for use as a pharmaceutical or dietary active ingredient
Zhao et al. Montmorillonite-enveloped zeolitic imidazolate framework as a nourishing oral nano-platform for gastrointestinal drug delivery
KR101740835B1 (ko) 작용화 탄산칼슘을 포함하는 속붕해성 고형 제형 제제 및 이의 제조 방법
JP7333941B2 (ja) 酸化ストレスに起因する疾患の予防又は治療剤
JP5894720B2 (ja) アルコール抵抗性製剤
KR20090094820A (ko) 철(ⅲ)-탄수화물-기재 인산염 흡착제
JP2010254618A (ja) カルニチン及びグリチルリチン酸含有経口固形剤
CN102008477A (zh) 一种瑞舒伐他汀钙片药物组合物的制备方法
JP3127998B2 (ja) 生物利用性の高められたプロブコールを含有する製剤組成物
CN100477999C (zh) 胶体果胶铋分散片
KR102055859B1 (ko) 아캄프로세이트 제제, 그것의 사용 방법, 및 그것을 포함하는 조합
JP7345824B2 (ja) うつ病又はうつ状態の予防又は治療剤
JP7461010B2 (ja) 虚血性脳血管障害に伴う障害の予防又は治療剤
JP7260353B2 (ja) コエンザイムｑ１０の固体分散体
CN107802842A (zh) 大蒜素矫味制剂及其制备方法
JP2021533144A (ja) 疼痛及び／又は発熱を予防及び／又は治療するための薬物、組成製品及びその応用
WO2019166656A1 (en) Highly structured porous silica materials and biological uses thereof
JP7267083B2 (ja) 還元型コエンザイムｑ１０を含む粉末組成物及び酸化防止剤
CN1323661C (zh) 脂酶抑制剂的用途
Murata et al. Functions of chitosan-ferulic acid salt for prevention of hypertension
CN102793716B (zh) 脂族胺聚合物的用途及其药物组合物和制备方法
TWI735658B (zh) 用於減少代謝症候群之組合物及其應用
WO2024117060A1 (ja) 腎臓保護剤およびその用途
JP2021187858A (ja) 医薬製剤
JP2023105249A (ja) 胃部不快感改善剤及び尿意抑制剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20151223